Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools

Overview

Health disparities in pediatric asthma persist, with Latino children demonstrating increased asthma morbidity. Middle school children with asthma have greater morbidity than children from any other age group and spend a majority of their day in school, where they must manage any asthma. The investigators developed and piloted a novel group-based intervention – ASMAS (Asthma Self-MAnagement in Schools) in two geographic areas with a high prevalence of urban and Latino children with asthma: Providence, Rhode Island, and San Juan, Puerto Rico. ASMAS is a 4-session, peer-facilitated asthma self-management intervention specific to the school setting for Latino middle school (6th-8th graders) children. It is delivered by trained High School Juniors and Seniors of Latino descent with asthma. The preliminary effects of ASMAS for improving asthma outcomes and self-management relative to controls were demonstrated in a previous intervention development study. This study will evaluate ASMAS through a large-scaled Randomized Control Trial with urban middle school students who have persistent asthma in Providence, Rhode Island and San Juan, Puerto Rico and will identify barriers and facilitators to the implementation of ASMAS. These results will inform future, large-scale dissemination in other urban school settings.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 15, 2023

Detailed Description

The goal of this study is to evaluate a 4-session, peer-facilitated asthma self-management intervention for Latino, middle school (6th-8th) youth in urban public school settings. The intervention, ASMAS (Asthma Self-Management in Schools) is administered by trained and supervised High School juniors and seniors of Latino descent with asthma to middle school peers with asthma. This study is a partnership with a second research group in San Juan, Puerto Rico, since there is also a high rate of asthma in children there. There are 2 goals in this study. The first goal is to evaluate the effects of ASMAS on asthma health outcomes (for example, asthma control, symptom free days, school absences and lung function) and on asthma self-management (skills, knowledge and self-efficacy, availability of rescue inhaler and action plan at school) in a sample of 432 Latino middle school children with asthma in Providence, Rhode Island and San Juan, Puerto Rico. Middle schoolers and a primary caregiver will complete a baseline research session, as well as, immediately post intervention and 4-month, 8-month and 12-month post intervention follow-up research home visits during which they will complete study questionnaires about the child's asthma. Students will be randomly assigned to one of three study groups. Assignment is random (like a coin toss), and what each student does in school depends on what group each student is assigned to. The ASMAS group and the Asthma + Health Education groups will learn about asthma and about other selected health topics during their in-school intervention sessions (1 per week for 4 weeks). The "no treatment" study group will not attend in-school group sessions at all. The second goal in the study is to evaluate the intervention in preparation for using it on a wider scale in other places. Students, caregivers, High School Peers, school administrators and additional community members will be invited to participate in group discussions about the intervention.

Interventions

  • Behavioral: ASMAS
    • A high school peer led group intervention for middles school students targeting asthma education and asthma management practices.
  • Behavioral: Asthma education plus child health
    • Health educator led intervention focused on asthma education and other child health topics.

Arms, Groups and Cohorts

  • Experimental: ASMAS
    • ASMAS is an asthma self-management program based on NHLBI clinical guidelines for optimal school-based asthma management. It involves 4, 1½ hour sessions delivered in group format in the urban, middle school setting by a Latino High School Peer who has asthma. ASMAS focuses on asthma pathophysiology, symptom management, asthma medications, and trigger control.
  • Active Comparator: Asthma education plus child health
    • Asthma Education plus Child Health control condition will be delivered by an adult Health Educator , and includes 4 sessions (1 1/2 hrs long) of our existing asthma education (“Asthma’s Magic Number”) with added general health topics (nutrition, physical activity, safety).
  • No Intervention: No Treatment Control
    • Students randomly assigned to this arm , will receive standard of care, which is no treatment, and will not participate in any group intervention sessions.

Clinical Trial Outcome Measures

Primary Measures

  • Change in asthma control
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • Assessed by child and parent report through the 7-item Child Asthma Control Test (C-ACT)
  • Change in symptom free days
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • By parent report using standard questionnaire of symptom-free days/nights in prior 30 days
  • Change in asthma related school absence ratio
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • Asthma related school absence ratio will be calculated from school attendance data and caregiver report of school absences due to asthma
  • Change in lung function
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • The Asthma Monitor 2 (AM2, ERT, USA) is a hand-held, computerized spirometer that collects pulmonary function indexes (Forced Expiratory Volume at one second, FEV1 ). Children will use AM2 during one week using standard procedures, 2x/day (before medications AM/PM). FEV1 predicted will be obtained.

Secondary Measures

  • Change in child asthma knowledge
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • Child report through the valid and reliable Asthma Knowledge Questionnaire
  • Change in child asthma self-efficacy
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • Child report through valid and reliable children’s Asthma Self-Efficacy Scale (Cronbach alpha .87; Bursch, et al, 1999). The scale includes 14 items with responses ranging from 1 to 6, and higher scores indicate more self-efficacy to care for asthma. An asthma self-efficacy score is calculated using the average of the 14 items.
  • Change in asthma self-management
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • Through a well-validated and reliable measure; child and caregiver versions
  • Change in asthma Action plan/Inhaler availability
    • Time Frame: Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
    • School Nurse report of Availability of rescue inhaler at school and asthma action plan with school nurse

Participating in This Clinical Trial

Inclusion Criteria specify that students must:

  • Be 11-14 years old – Attend 6th, 7th or 8th grade – attend a targeted public school – have physician-diagnosed asthma according to caregiver and provider report – meet criteria for current persistent asthma either by a) having a current prescription for an asthma controller medicine, or b) having any of the following in the previous 4 weeks: I. daytime asthma symptoms > 2 days/week, II. nighttime awakenings due to asthma at least 3-4 times/month, III. short-acting beta agonist use at least 2 days/week, IV. activity limitation, or V. oral steroid use at least 2 times/year – children must have recent active asthma activity in the previous 4 weeks through endorsement of any of criteria I-V above – In Rhode Island, children's primary caregiver must identify as Latino – In Rhode Island, children must speak English Exclusion criteria:

  • active immunotherapy, – other pulmonary disease, – receiving special education services in a self-contained classroom, – any severe psychiatric or medical conditions

Gender Eligibility: All

Minimum Age: 11 Years

Maximum Age: 14 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Rhode Island Hospital
  • Collaborator
    • University of Puerto Rico
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Daphne Koinis-Mitchell, PhD, Principal Investigator, Rhode Island Hospital
    • Glorisa Canino, PhD, Principal Investigator, University of Puerto Rico
    • Maria T Coutinho, PhD, Study Director, Rhode Island Hospital
  • Overall Contact(s)
    • Daphne Koinis-Mitchell, PhD, (401) 793-3682, dkoinismitchell@lifespan.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.